Blue Water Life Science Advisors, LP
•CIK: 1789778•Filing: Q4 2025
**Blue Water Life Science Advisors, LP** manages $159M across a concentrated portfolio of 9 positions, emphasizing high-conviction opportunities within the life sciences sector. The fund exhibits significant exposure to key biopharma names, notably holding GH at $36.3M and NTRA at $32.4M. Further substantial allocations include ADPT ($28.7M) and PSNL ($13.3M), signaling deep sector conviction. This structure suggests a focused, research-intensive approach targeting disruptive advancements in biotechnology.
Total AUM
$159.3M
QoQ Performance
+45.4%
Positions
9
Top 10 Concentration
100.0%
Latest Filing
Q4 2025
Top Holdings Allocation
GH
NTRA
ADPT
PSNL
QTRX
TWST
CDNA
GRAL
GH22.8%
NTRA20.3%
ADPT18.0%
PSNL8.4%
QTRX8.4%
TWST7.6%
CDNA6.0%
GRAL5.3%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other100.0%
Changes from Q3 2025
NEW2 new positions
↑2 increased
↓2 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023